Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vanda Pharmaceuticals (VNDA) Return on Assets (2016 - 2025)

Historic Return on Assets for Vanda Pharmaceuticals (VNDA) over the last 16 years, with Q3 2025 value amounting to 0.14%.

  • Vanda Pharmaceuticals' Return on Assets fell 1100.0% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year decrease of 1100.0%. This contributed to the annual value of 0.03% for FY2024, which is 300.0% down from last year.
  • As of Q3 2025, Vanda Pharmaceuticals' Return on Assets stood at 0.14%, which was down 1100.0% from 0.11% recorded in Q2 2025.
  • Vanda Pharmaceuticals' 5-year Return on Assets high stood at 0.06% for Q3 2021, and its period low was 0.14% during Q3 2025.
  • Moreover, its 5-year median value for Return on Assets was 0.01% (2022), whereas its average is 0.0%.
  • The largest annual percentage gain for Vanda Pharmaceuticals' Return on Assets in the last 5 years was 200bps (2021), contrasted with its biggest fall of -1800bps (2021).
  • Vanda Pharmaceuticals' Return on Assets (Quarter) stood at 0.06% in 2021, then crashed by -82bps to 0.01% in 2022, then plummeted by -61bps to 0.0% in 2023, then crashed by -847bps to 0.03% in 2024, then crashed by -373bps to 0.14% in 2025.
  • Its Return on Assets was 0.14% in Q3 2025, compared to 0.11% in Q2 2025 and 0.07% in Q1 2025.